TAU2106C1.MS

General

Cell Line

hPSCreg name TAUi008-A
Cite as:
TAUi008-A (RRID:CVCL_C1JP)
Alternative name(s)
TAU2106C1.MS
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
ESi048-A
(MS FiPS 1-R4F-3)
Donor diseases:
obsolete_multiple sclerosis
ESi051-A
(MS FiPS 4-R4F-1)
Donor diseases:
obsolete_multiple sclerosis
ESi052-A
(MS FiPS 5-R4F-6)
Donor diseases:
Multiple Sclerosis
ESi053-A
(MS FiPS 6-R4F-2)
Donor diseases:
Multiple Sclerosis
ESi049-A
(MS FiPS 2 R4F-10)
Donor diseases:
obsolete_multiple sclerosis
ESi050-A
(MS FiPS 3-R4F-1)
Donor diseases:
Multiple Sclerosis
SIAISi006-A
(JJY)
Donor diseases:
Alzheimer's Disease
MUNIi021-A
(sAD5)
Donor diseases:
Alzheimer's Disease
ASGRCi003-A
(F3-4#5 CHR)
Donor diseases:
Type 1 Diabetes Mellitus
JUCGRMi003-A
(PH13)
Donor diseases:
Parkinson's Disease
BIOTi001-A
(BIOT-7183-PSEN1)
Donor's gene variants:
PSEN1
Donor diseases:
obsolete_Alzheimer's disease
QBRIi005-A
Donor diseases:
Psoriasis
LNDWCHi001-A
(LNDWCH-iPS-PD-PLA2G6–001)
Donor diseases:
Parkinson Disease
QBRIi005-B
Donor diseases:
Psoriasis
QBRIi005-C
Donor diseases:
Psoriasis
UMi043-A
(AD 381852 clone #1)
Donor diseases:
Alzheimer's Disease
DMBi007-A
Donor diseases:
Psoriasis
PNUSCRi004-A
(GBA PD iPSC8)
Donor diseases:
Parkinson's Disease
MUNIi011-A
(BAD1, sAD1)
Donor diseases:
Alzheimer's Disease
MUNIi012-A
(BAD2, sAD2)
Donor diseases:
Alzheimer's Disease
UMi041-A
(410730)
Donor diseases:
Alzheimer's Disease
JUCGRMi002-A
(DupA5)
Donor diseases:
Parkinson's Disease
JUCGRMi002-B
(DupA13)
Donor diseases:
Parkinson's Disease
JUCGRMi002-C
(DupA18)
Donor diseases:
Parkinson's Disease
IPTi002-A
(15F0009)
Donor diseases:
obsolete_Alzheimer's disease
SHFDi001-A
(SHFD-1)
Donor diseases:
Ankylosing Spondylitis
SPHi001-A
(SLEi002HZY)
Donor diseases:
Systemic Lupus Erythematosus
CBIGi002-A
(2890 (GBA W378G, heterozygous), 2890)
Donor's gene variants:
GBA, GBA
Donor diseases:
Parkinson's Disease
Last update 11th July 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Tampere University (TAU)
Derivation country Finland

External Databases

BioSamples SAMEA14263389
Cellosaurus CVCL_C1JP
Wikidata Q114313098

General Information

Publications
* Is the cell line readily obtainable for third parties?
No

Donor Information

General Donor Information

Sex female
Ethnicity Caucasian

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is affected.
Synonyms
  • Multiple Sclerosis
  • multiple sclerosis
  • Multiple sclerosis

Karyotyping (Donor)

Has the donor karyotype been analysed?
No

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA110255789

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Provide contact information of the holder of the original Donor Information Sheet: laura.airas@utu.fi
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Contact information / weblink laura.airas@utu.fi
Alternatives to consent are available? No
Is there other documentation provided to the donor for consenting purposes? No
Confirm that consent was obtained by a qualified professional Yes
Has the donor been informed about how her/his data will be protected? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? Yes

Does consent permit research by

an academic institution? Yes
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Ethics Committee, Hospital District of Southwest Finland
Approval number 48/1801/2019
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
  • PERIPHERAL BLOOD MONONUCLEAR CELL
  • Peripheral Blood Mononuclear Cell
  • PBMC

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Genes
Is reprogramming vector detectable?
No
Methods used
RT-PCR
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Type of used vector free reprogramming factor(s)
None

Other

Selection criteria for clones Morphology
Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Non coated
Feeder cells Human Foreskin Fibroblast
Cellfinder Ont Id: CELDA_000001419
Passage method Mechanically
CO2 Concentration 5 %
Medium Other medium:
Base medium: KnockOut DMEM
Main protein source: Knock-out serum replacement
Serum concentration: 20 %
Supplements
GlutaMAX
NEAA
Pen/Strep
β-mercaptoethanol
bFGF
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
No

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
SOX2
Yes
NANOG
Yes
SSEA-4
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro spontaneous differentiation
Marker Expressed
SOX17
Yes
AFP
Yes
Morphology
Mesoderm
Ont Id: UBERON_0000926
In vitro spontaneous differentiation
Marker Expressed
ACTA2
Yes
Morphology
Ectoderm
Ont Id: UBERON_0000924
In vitro spontaneous differentiation
Marker Expressed
OTX2
Yes
Morphology

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46XX
Passage number: 21
Karyotyping method: G-Banding

Other Genotyping (Cell Line)